These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8930577)

  • 21. Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.
    Hawkey CJ; Atherton JC; Treichel HC; Thjodleifsson B; Ravic M
    Aliment Pharmacol Ther; 2003 Apr; 17(8):1065-74. PubMed ID: 12694089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of Helicobacter pylori resistance on the efficacy of a short course pantoprazole based triple therapy.
    Eisig JN; André SB; Silva FM; Hashimoto C; Moraes-Filho JP; Laudanna AA
    Arq Gastroenterol; 2003; 40(1):55-60. PubMed ID: 14534667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in Brazilian patients with peptic ulcer.
    Silva FM; Zaterka S; Eisig JN; Chehter EZ; Chinzon D; Laudanna AA
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(1):11-6. PubMed ID: 11378678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.
    Vallve M; Vergara M; Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2002 Jun; 16(6):1149-56. PubMed ID: 12030958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid improvement of symptomatology with pantoprazole, amoxycillin and metronidazole in Helicobacter pylori-positive duodenal ulcer patients.
    Pilotto A; Leandro G; Franceschi M; Bierti L; Di Battista R; Notarbartolo A; Pisciotta G; Grassi A; Crestani B; Tafner G; Michelagnoli S; Garotta F
    Hepatogastroenterology; 1999; 46(25):245-51. PubMed ID: 10228801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori.
    Ellenrieder V; Fensterer H; Waurick M; Adler G; Glasbrenner B
    Aliment Pharmacol Ther; 1998 Jul; 12(7):613-8. PubMed ID: 9701524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
    Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
    Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection.
    de Boer SY; v d Meeberg PC; Siem H; de Boer WA
    Neth J Med; 2003 Jun; 61(6):218-22. PubMed ID: 12956102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment.
    Wheeldon TU; Hoang TT; Phung DC; Björkman A; Granström M; Sörberg M
    Aliment Pharmacol Ther; 2003 Jul; 18(1):93-100. PubMed ID: 12848630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
    Langtry HD; Markham A
    Drugs; 1999 Oct; 58(4):725-42. PubMed ID: 10551440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial.
    Svoboda P; Kantorová I; Ochmann J; Doubek J; Kozumplík L; Marsová J
    Hepatogastroenterology; 1997; 44(15):886-90. PubMed ID: 9222709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis.
    Gisbert JP; Khorrami S; Calvet X; Pajares JM
    Eur J Gastroenterol Hepatol; 2004 Jan; 16(1):89-99. PubMed ID: 15095858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen.
    Catalano F; Branciforte G; Catanzaro R; Cipolla R; Bentivegna C; Brogna A
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1329-34. PubMed ID: 11012478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection.
    Wu CJ; Hsu PI; Lo GH; Lo CC; Lin CK; Shie CB; Peng NJ; Tseng HH; Jou HS; Tsai PM; Chen A; Chen JL; Lai KH
    J Chin Med Assoc; 2004 Apr; 67(4):161-7. PubMed ID: 15244013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients.
    Goh K; Parasakthi N; Cheah P; Ranjeev C; Rosmawati M; Tan Y; Chin S
    J Gastroenterol Hepatol; 2000 Aug; 15(8):910-4. PubMed ID: 11022833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype.
    Inaba T; Mizuno M; Kawai K; Yokota K; Oguma K; Miyoshi M; Take S; Okada H; Tsuji T
    J Gastroenterol Hepatol; 2002 Jul; 17(7):748-53. PubMed ID: 12121503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin.
    Furuta T; Shirai N; Xiao F; Takashita M; Sugimoto M; Kajimura M; Ohashi K; Ishizaki T
    Hepatogastroenterology; 2003; 50(54):2274-8. PubMed ID: 14696516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week.
    Abdul Aal GM; Dajani AI; Nounou M; Awad S; Abdul Rasheed Z; Gautam S; Ukabam S; Nayal S
    Digestion; 1999; 60(3):286-97. PubMed ID: 10343145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection.
    Gawrońska-Szklarz B; Wrześniewska J; Starzyńska T; Pawlik A; Safranow K; Ferenc K; Droździk M
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):375-9. PubMed ID: 15976989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
    Cheer SM; Prakash A; Faulds D; Lamb HM
    Drugs; 2003; 63(1):101-33. PubMed ID: 12487624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.